Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
meeting crawled date : 2022 - 06 - 03 save search
Arcellx Presents Continued Robust Long-Term Responses from its CART-ddBCMA Phase 1 Expansion Trial in Patients with Relapsed or Refractory Multiple Myeloma at the 2022 ASCO Annual Meeting
Published: 2022-06-03 (Crawled : 21:00) - prnewswire.com
ACLX | $54.44 4.69% 4.46% 410K
|
| Email alert
Add to watchlist
expansion trial asco phase 1
SANDSTORM GOLD ROYALTIES ANNOUNCES VOTING RESULTS FROM 2022 ANNUAL SHAREHOLDER MEETING
Published: 2022-06-03 (Crawled : 21:00) - prnewswire.com
SAND | $5.36 1.9% 0.37% 1.6M
|
Non-Energy Minerals
| Email alert
Add to watchlist
royalties results
Investigators from US Oncology Research, The US Oncology Network and Ontada Present Data Highlighting Key Advances and Insights at the 2022 American Society of Clinical Oncology Annual Meeting
Published: 2022-06-03 (Crawled : 15:00) - biospace.com/
MCK | $532.0 0.89% -0.13% 490K
|
Distribution Services
|
| O: 0.0%
H: 0.81%
C: -0.69%
American Airlines to Webcast Annual Meeting of Stockholders
Published: 2022-06-03 (Crawled : 14:20) - globenewswire.com
AAL | $14.23 -2.07% -2.18% 38M
|
Transportation
|
| O: -2.63%
H: 0.29%
C: -4.59%
Summit Therapeutics’ Upcoming Annual Shareholders’ Meeting Rescheduled to June 16, 2022, at 1:00pm Eastern Time
Published: 2022-06-03 (Crawled : 13:20) - biospace.com/
SMMT | $3.72 6.59% 6.18% 1.8M
|
Health Technology
|
| O: -8.24%
H: 0.85%
C: -3.42%
Kintara Granted 180-Day Extension to Meet Nasdaq Minimum Bid Price Requirement
Published: 2022-06-03 (Crawled : 13:20) - prnewswire.com
KTRA | $0.1327 16.1% 12.68% 7.4M
|
Distribution Services
|
| O: 6.46%
H: 1.09%
C: -2.95%
nasdaq granted grant
Kelso Technologies Inc. Announces 2022 Annual General Meeting Results
Published: 2022-06-03 (Crawled : 13:20) - globenewswire.com
KIQ | $0.1349 0.0% 12K
|
Producer Manufacturing
|
| O: -5.63%
H: 7.07%
C: 5.66%
results
Novocure and Zai Lab Announce EF-31 Phase 2 Pilot Study Evaluating Tumor Treating Fields Together with Standard-of-Care Chemotherapy Meets Primary Endpoint for First-Line Treatment of Gastric Cancer
Published: 2022-06-03 (Crawled : 13:00) - biospace.com/
NVCR | $12.055 1.9% 1.87% 600K
|
Health Technology
|
| O: 5.37%
H: 2.15%
C: -4.71%
ef-31 treatment cancer
Nurix Therapeutics Will Present Trial in Progress Posters for Three Clinical Programs at the Annual Meeting of the American Society of Clinical Oncology (ASCO)
Published: 2022-06-03 (Crawled : 12:20) - biospace.com/
NRIX 6 d | $14.13 4.05% 3.86% 900K
|
Health Technology
|
| O: -4.11%
H: 17.32%
C: 16.28%
trial therapeutics
TG Therapeutics Announces Presentation of Exploratory Analyses from the ULTIMATE I & II Phase 3 Trials of Ublituximab in Multiple Sclerosis at the 2022 Consortium of Multiple Sclerosis Centers Annual Meeting
Published: 2022-06-03 (Crawled : 12:00) - globenewswire.com
TGTX | $14.25 1.06% 1.05% 3.2M
|
Health Technology
|
| O: 5.63%
H: 11.62%
C: 6.54%
trials therapeutics presentation sclerosis phase 3 multiple sclerosis
Altitude Acquisition Corp. Announces Intent to Adjourn Special Meeting to Approve Extension Proposal
Published: 2022-06-03 (Crawled : 11:00) - globenewswire.com
ALTU | $10.12 0.0% 69K
|
|
| O: 0.0%
H: 0.1%
C: -0.1%
acquisition proposal
New 12-Month Tofersen Data Presented at ENCALS Meeting Show Clinically Meaningful Benefit in People With SOD1-ALS
Published: 2022-06-03 (Crawled : 10:00) - globenewswire.com
IONS | $41.84 1.88% 1.86% 630K
|
Health Technology
|
| O: 0.11%
H: 2.24%
C: 1.03%
BIIB | $193.18 -0.48% -0.48% 1.2M
|
Health Technology
|
| O: 1.16%
H: 3.3%
C: 1.27%
Biotech Acquisition Company and Blade Therapeutics Announce Postponement of Extraordinary Meeting of Shareholders to Approve Proposed Business Combination
Published: 2022-06-03 (Crawled : 02:00) - prnewswire.com
BIOT | $10.15 -0.78% -0.2% 44K
|
|
| O: 6.09%
H: 1.54%
C: 1.44%
acquisition biotech therapeutics
High Tide Announces Voting Results of Annual General and Special Meeting of Shareholders
Published: 2022-06-03 (Crawled : 02:00) - prnewswire.com
HITI | $2.14 -0.47% -0.7% 530K
|
Manufacturing
|
| O: 5.04%
H: 0.73%
C: -1.11%
results
Adverum Biotechnologies Announces New Data at the Macula Society’s 2022 Annual Meeting
Published: 2022-06-02 (Crawled : 01:00) - biospace.com/
ADVM | News | $11.0 -3.0% -3.47% 310K
|
Health Technology
|
| O: 1.14%
H: 0.0%
C: 0.0%
Gainers vs Losers
| 77% | 23% |
Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 26M
|
AGBA | $2.97 137.6% 57.48% 66M
|
Finance
EDBL | News | $6.59 75.27% 41.8% 2M
|
MTC | $2.24 43.59% 30.67% 6M
|
Technology Services
OPRT | News | $3.15 40.0% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.33 30.39% 24.16% 390K
|
Technology Services
ABVC | $1.35 29.81% 23.53% 7.1M
|
Wholesale Trade
OST | $0.5 25.0% 21.88% 280K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.